AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Snipd AI
This podcast discusses Nvidia's blowout earnings and the potential impact of AI. It covers Splunk's stock rally after their earnings report. It also touches on the ongoing presence of COVID-19 and the development of a new Lyme vaccine. Finally, it explores the use of AI in the retail industry to tackle shrinkage.
Read more
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- A new Lyme disease vaccine from Pfizer and Valneva is expected to be available in 2026, potentially addressing the increasing prevalence of Lyme disease and public fear of tick bites.
- Vaccine hesitancy and concerns about side effects may affect the reception of a new Lyme disease vaccine, despite the potential market demand.
Deep dives
The history of the Lyme disease vaccine
The first Lyme disease vaccine for humans, Lymorex, was approved in 1998, but it failed to gain traction and was eventually pulled from the market due to vaccine skepticism at the time.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode